Physician profile
Ali Dahhan
NPI 1770713364
$6,299.45
in general payments reported to CMS, 2019-2025
27 companies · $167 in 2025
The $167 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,638 · 2020: $499 · 2021: $412 · 2022: $379 · 2023: $625 · 2024: $580 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,371.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,783.79 | 2019 | |
| Abbott Laboratories | $692.62 | 2019-2020 | |
| Medtronic, INC. | $461.62 | 2021-2024 | Linq II, Micra, Reveal Linq |
| Novartis Pharmaceuticals Corporation | $395.08 | 2019-2025 | |
| Inari Medical, INC. | $344.96 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals LP | $238.42 | 2020-2023 | Farxiga |
| Edwards Lifesciences Corporation | $233.60 | 2022-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Janssen Pharmaceuticals, INC | $204.64 | 2019-2022 | |
| Pfizer INC. | $138.64 | 2021-2025 | |
| Angiodynamics, INC. | $131.58 | 2023 | Auryon Laser System 100-120 Vac |
| Cardinal Health 200 LLC | $111.80 | 2019 | |
| Shockwave Medical, INC | $65.58 | 2021 | |
| Medtronic Vascular, INC. | $58.96 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $58.65 | 2024-2025 | Lifevest |
| Cardiovascular Systems INC. | $57.66 | 2019-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $47.47 | 2022-2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.82 | 2021 | |
| W. L. Gore & Associates, INC. | $34.47 | 2021 | |
| Terumo Medical Corporation | $27.75 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $27.34 | 2023 | Camzyos |
| Amarin Pharma, INC. | $23.01 | 2021 | |
| Cardiva Medical, INC. | $19.95 | 2025 | Optowire |
| Lexicon Pharmaceuticals, INC. | $19.83 | 2023 | Inpefa |
| Bayer Healthcare Pharmaceuticals INC. | $19.20 | 2025 | |
| Zoll Circulation INC | $19.00 | 2021 | |
| Impulse Dynamics (USA) INC. | $18.52 | 2023 | Optimizer |
| Philips North America LLC | $18.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Dahhan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.